QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)

PAVmed - PAVM Stock Forecast, Price & News

$0.36
-0.01 (-2.55%)
(As of 03/29/2023 03:57 PM ET)
Add
Compare
Today's Range
$0.35
$0.37
50-Day Range
$0.36
$0.57
52-Week Range
$0.35
$2.34
Volume
206,964 shs
Average Volume
465,689 shs
Market Capitalization
$34.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.56

PAVmed MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
900.7% Upside
$3.56 Price Target
Short Interest
Bearish
8.52% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.78
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.86 out of 5 stars

Medical Sector

796th out of 999 stocks

Surgical & Medical Instruments Industry

80th out of 103 stocks


PAVM stock logo

About PAVmed (NASDAQ:PAVM) Stock

PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY.

Receive PAVM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter.

PAVM Stock News Headlines

Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
PAVmed Inc. (PAVM) Q3 2022 Earnings Call Transcript
PAVmed to Participate in BTIG Digital Health Forum
Does PAVmed (NASDAQ:PAVM) Have A Healthy Balance Sheet?
See More Headlines
Receive PAVM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter.

PAVM Company Calendar

Last Earnings
8/12/2021
Today
3/29/2023
Next Earnings (Estimated)
5/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PAVM
Fax
N/A
Employees
25
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.56
High Stock Price Forecast
$8.25
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+911.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-88,980,000.00
Pretax Margin
-27,384.09%

Debt

Sales & Book Value

Annual Sales
$380,000.00
Book Value
$0.09 per share

Miscellaneous

Free Float
85,429,000
Market Cap
$34.65 million
Optionable
Not Optionable
Beta
0.88

Key Executives

  • Lishan Aklog
    Chairman & Chief Executive Officer
  • Dennis M. McGrath
    President, Chief Financial Officer & Secretary
  • Shaun M. O’Neil
    Chief Operating Officer & Executive Vice President
  • Brian J. deGuzman
    Chief Medical Officer
  • James Mitchell
    Vice President-Digital Health













PAVM Stock - Frequently Asked Questions

Should I buy or sell PAVmed stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PAVmed in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PAVM shares.
View PAVM analyst ratings
or view top-rated stocks.

What is PAVmed's stock price forecast for 2023?

2 Wall Street research analysts have issued 12 month price targets for PAVmed's shares. Their PAVM share price forecasts range from $1.50 to $8.25. On average, they anticipate the company's stock price to reach $3.56 in the next twelve months. This suggests a possible upside of 911.8% from the stock's current price.
View analysts price targets for PAVM
or view top-rated stocks among Wall Street analysts.

How have PAVM shares performed in 2023?

PAVmed's stock was trading at $0.48 at the start of the year. Since then, PAVM shares have decreased by 26.6% and is now trading at $0.3521.
View the best growth stocks for 2023 here
.

When is PAVmed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our PAVM earnings forecast
.

How were PAVmed's earnings last quarter?

PAVmed Inc. (NASDAQ:PAVM) posted its quarterly earnings results on Thursday, August, 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $0.04.

What other stocks do shareholders of PAVmed own?
What is PAVmed's stock symbol?

PAVmed trades on the NASDAQ under the ticker symbol "PAVM."

Who are PAVmed's major shareholders?

PAVmed's stock is owned by many different institutional and retail investors. Top institutional investors include Wells Fargo & Company MN (0.38%), Millennium Management LLC (0.33%), Levin Capital Strategies L.P. (0.29%), Verition Fund Management LLC (0.14%), Morgan Stanley (0.14%) and Belpointe Asset Management LLC (0.10%). Insiders that own company stock include Lishan Aklog, Matthew Sirovich, Michael J Glennon and Pavmed Inc.
View institutional ownership trends
.

How do I buy shares of PAVmed?

Shares of PAVM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PAVmed's stock price today?

One share of PAVM stock can currently be purchased for approximately $0.35.

How much money does PAVmed make?

PAVmed (NASDAQ:PAVM) has a market capitalization of $34.65 million and generates $380,000.00 in revenue each year. The company earns $-88,980,000.00 in net income (profit) each year or ($1.01) on an earnings per share basis.

How can I contact PAVmed?

PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The official website for the company is www.pavmed.com. The company can be reached via phone at (212) 949-4319 or via email at jmh@pavmed.com.

This page (NASDAQ:PAVM) was last updated on 3/29/2023 by MarketBeat.com Staff